Financial Avengers’s Takeda Pharmaceutical TAK Stock Holding History

Financial Avengers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.1K	Sell	1,750 -750	-30%	-$12.4K	0.01%	85
2026 Q1	$46.3K	Hold	2,500	–	–	0.02%	63
2025 Q4	$39K	Hold	2,500	–	–	0.02%	69
2025 Q3	$36.6K	Sell	2,500 -855	-25%	-$12.7K	0.02%	72
2025 Q2	$51.9K	Sell	3,355 -645	-16%	-$9.53K	0.02%	61
2025 Q1	$59.5K	Sell	4,000 -2,211	-36%	-$31K	0.03%	57
2024 Q4	$82.2K	Hold	6,211	–	–	0.04%	50
2024 Q3	$88.3K	Buy	6,211 +3,355	+117%	+$47.6K	0.04%	51
2024 Q2	$37K	Hold	2,856	–	–	0.02%	68
2024 Q1	$39K	Hold	2,856	–	–	0.02%	67
2023 Q4	$40.8K	Hold	2,856	–	–	0.02%	63
2023 Q3	$44.2K	Buy	+2,856	New	+$44.2K	0.03%	60

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Financial Avengers's TAK Position: Q2 2026 in Review

Financial Avengers reduced its Takeda Pharmaceutical (TAK) stake by 30% in Q2 2026, selling an estimated $12.4K and leaving 1,750 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #85.

Financial Avengers first reported a position in TAK in Q3 2023 and has held it in 12 quarters since. The position peaked at $88.3K in Q3 2024. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Financial Avengers held 1,750 shares of Takeda Pharmaceutical worth $28.1K as of Q2 2026.
Financial Avengers sold 750 Takeda Pharmaceutical shares in Q2 2026, an estimated $12.4K.
Takeda Pharmaceutical made up 0.01% of Financial Avengers's portfolio in Q2 2026, its #85 holding.
Financial Avengers first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
Financial Avengers's Takeda Pharmaceutical position peaked at $88.3K in Q3 2024.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.